A Randomized, Double-blind, Placebo-controlled, Parallel Group, Multi-center Trial Of Pregabalin As Adjunctive Therapy In Pediatric And Adult Subjects With Primary Generalized Tonic-clonic Seizures - Protocol A0081105
Phase of Trial: Phase III
Latest Information Update: 13 Aug 2018
At a glance
- Drugs Pregabalin (Primary)
- Indications Tonic-clonic epilepsy
- Focus Adverse reactions; Registrational; Therapeutic Use
- Sponsors Pfizer
- 07 Aug 2018 This trial was completed in Denmark, according to European Clinical Trials Database.
- 20 Jul 2018 Planned End Date changed from 30 Jun 2019 to 5 Jul 2019.
- 20 Jul 2018 Planned primary completion date changed from 30 Jun 2019 to 5 Jul 2019.